{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-018762","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.076147+00:00","generated_at":"2026-06-13T15:52:03.777774+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vaxart stockholders re-elect six directors, ratify auditor, and approve say-on-pay at 2023 annual meeting","bullets":["All six director nominees elected; highest votes for Elaine J. Heron, Ph.D. (28,489,847 for), lowest Robert A. Yedid (23,166,022 for).","Ratification of WithumSmith+Brown as auditor for FY2023 passed with 67,434,986 votes for, 3,868,365 against.","Say-on-pay advisory resolution approved with 18,890,423 votes for, 11,637,307 against; 42,397,502 broker non-votes.","Stockholders recommended a 1-year frequency for future say-on-pay votes (25,454,444 votes for every year).","Quorum achieved with 54.75% of outstanding shares represented."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-018762","json":"https://secwatch.observer/filing/0001437749-23-018762.json","markdown":"https://secwatch.observer/filing/0001437749-23-018762.md","text":"https://secwatch.observer/filing/0001437749-23-018762.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774923018762/0001437749-23-018762-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774923018762/vxrt20230628_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:52:03.777774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"650daa6ac47dc9382b074ec794e5f61a05176682","claim":"Vaxart, Inc. shareholders approved Non-binding advisory vote on the frequency of the advisory vote on executive compensation at the 2023-06-26 meeting.","evidence_excerpt":"Proposal 4 . Stockholders voted on a non-binding advisory basis on the frequency of the advisory vote on the compensation of the Company’s named executive officer (the “Say-on-Frequency Proposal”). The voting results were as follows: Once Every Year Every Two Years Every Three Years Abstain 25,454,444 1,853,035 1,867,998 2,679,132","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923018762/0001437749-23-018762-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"97bda748344cd5e65c9c6fc3b4aaeeb9f23e6212","claim":"Vaxart, Inc. shareholders approved Election of six nominees for directors to serve until the 2024 annual meeting at the 2023-06-26 meeting.","evidence_excerpt":"Proposal 1 . Stockholders elected the six nominees for directors to serve until the Company’s 2024 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified. The voting results were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Michael J. Finney, Ph.D. 27,992,065 3,862,544 42,397,502 Andrei Floroiu 23,771,964 8,082,645 42,397,502 Elaine J. Heron, Ph.D. 28,489,847 3,364,762 42,397,502 W. Mark Watson 27,950,477 3,904,132 42,397,502 David Wheadon, M.D. 27,167,509 4,687,100 42,397,502 Robert A. Yedid 23,166,022 8,688,587 42,397,502","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923018762/0001437749-23-018762-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"a3564e42c84509e52c7f9a211cf955cbf491a5f5","claim":"Vaxart, Inc. shareholders approved Ratification of the selection of WithumSmith+Brown, PC as independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-26 meeting.","evidence_excerpt":"Proposal 2 . Stockholders ratified the selection of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the year ending December 31, 2023. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 67,434,986 3,868,365 2,948,760 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923018762/0001437749-23-018762-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"},{"claim_id":"a4143e9a01a8555e34a6453e705271c535286c8e","claim":"Vaxart, Inc. shareholders approved Non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in the Proxy Statement at the 2023-06-26 meeting.","evidence_excerpt":"Proposal 3 . Stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 18,890,423 11,637,307 1,326,879 42,397,502","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923018762/0001437749-23-018762-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-26"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}